Dimensional Fund Advisors’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
NCNMGF
MBAM
Dimensional Fund Advisors's XGN Position: Q3 2026 in Review
Dimensional Fund Advisors sold out of Exagen (XGN) in Q3 2026, closing a stake of 62,571 shares — an estimated $291K sold.
Dimensional Fund Advisors first reported a position in XGN in Q2 2021 and held it in 20 quarters. The position peaked at $579K in Q1 2022. 48 funds tracked by Wall St. Rank hold XGN as of Q3 2026.
- Dimensional Fund Advisors reported no remaining Exagen position as of Q3 2026 after selling out during the quarter.
- Dimensional Fund Advisors sold 62,571 Exagen shares in Q3 2026, an estimated $291K.
- Dimensional Fund Advisors first reported a position in Exagen in Q2 2021 and held it in 20 quarters.
- Dimensional Fund Advisors's Exagen position peaked at $579K in Q1 2022.
- 48 funds tracked by Wall St. Rank held Exagen as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.